34671829|PMC8527966
{'Chemical', 'Disease', 'Species', 'Gene'}
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), puts a heavy strain on healthcare systems around the globe with high numbers of infected patients. Several studies demonstrated the high incidence of thromboembolism that affects both the arterial and the venous system. Several studies demonstrated that patients with a history of cardiovascular comorbidities have a higher risk for an aggravated clinical course of COVID-19.In addition to the described direct cardiovascular complications induced by a COVID-19, the pandemic might have several indirect consequences due to a pandemic-related reduction in diagnostic and therapeutic strategies for patients with cardiovascular disease (; Fig.